These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8925345)

  • 21. Helping clozapine help: a role for support groups.
    Zita DF; Goethe J
    Schizophr Bull; 2002; 28(1):123-6. PubMed ID: 12047011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Life planning and psychosis--treatment of schizophrenia in unusual circumstances].
    Jung S
    Psychiatr Prax; 1996 May; 23(3):144-5. PubMed ID: 8711008
    [No Abstract]   [Full Text] [Related]  

  • 23. Clozapine-induced hypotension treated with moclobemide and Bovril.
    Taylor D; Reveley A; Faivre F
    Br J Psychiatry; 1995 Sep; 167(3):409-10. PubMed ID: 7496658
    [No Abstract]   [Full Text] [Related]  

  • 24. Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (gen-clozapine).
    Oluboka O; Stewart S; Landry S; Adams S
    J Clin Pharmacol; 2010 May; 50(5):531-5. PubMed ID: 20089825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Training hospitalized patients with schizophrenia in community reintegration skills.
    Smith TE; Hull JW; MacKain SJ; Wallace CJ; Rattenni LA; Goodman M; Anthony DT; Kentros MK
    Psychiatr Serv; 1996 Oct; 47(10):1099-103. PubMed ID: 8890338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.
    Scheepers FE; de Wied CC; Hulshoff Pol HE; van de Flier W; van der Linden JA; Kahn RS
    Neuropsychopharmacology; 2001 Jan; 24(1):47-54. PubMed ID: 11106875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restarting clozapine: a case report.
    Barrons E; Johnson E; Nynkowski P
    Psychiatr Serv; 1996 Jan; 47(1):92. PubMed ID: 8925356
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use.
    Nguyen AS; Grossman-Kahn R; Wichser L
    J Clin Psychopharmacol; 2020; 40(6):618-619. PubMed ID: 33065717
    [No Abstract]   [Full Text] [Related]  

  • 29. Once- to twice-daily, 3-year domiciliary maintenance transcranial direct current stimulation for severe, disabling, clozapine-refractory continuous auditory hallucinations in schizophrenia.
    Andrade C
    J ECT; 2013 Sep; 29(3):239-42. PubMed ID: 23377748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond medication. What else does the patient with schizophrenia need to reintegrate into the community?
    Castle LN
    J Psychosoc Nurs Ment Health Serv; 1997 Sep; 35(9):18-21. PubMed ID: 9298460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
    Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

  • 37. Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modification.
    Müller P; Bandelow B; Gaebel W; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Schaefer E; Tegeler J
    Br J Psychiatry Suppl; 1992 Oct; (18):140-4. PubMed ID: 1356364
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Starting patients on clozapine in a partial hospitalization program.
    Johnson CG; Littrell KH; Magill AM
    Hosp Community Psychiatry; 1994 Mar; 45(3):264-8. PubMed ID: 8188200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Effectiveness and Safety of Clozapine Between Once-Daily and Divided Dosing Regimen in Patients With Treatment-Resistant Schizophrenia.
    Sathienluckana T; Jansing T; Srisuriyakamon S; Thonkhunthod A; Sangsuwanto P; Losatiankij P; Supanya S
    Ann Pharmacother; 2024 Jun; 58(6):598-604. PubMed ID: 37743679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.